Standard
Optimizatsiya gipolipidemicheskoi terapii u patsientov, perenesshikh ishemicheskii insul't. Rezolyutsiya Soveta ekspertov. / Vozniuk, I. A.; Shamalov, N. A.; Ezhov, M. V.; Tikhomirova, O. V.; Gurevich, V. S.; Kucherenko, S. S.; Konovalov, G. A.; Konstantinov, V. O.; Ershova, A. I.
In:
Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, Vol. 120, No. 6, 2020, p. 152-161.
Research output: Contribution to journal › Review article › peer-review
Harvard
Vozniuk, IA, Shamalov, NA, Ezhov, MV, Tikhomirova, OV
, Gurevich, VS, Kucherenko, SS, Konovalov, GA, Konstantinov, VO & Ershova, AI 2020, '
Optimizatsiya gipolipidemicheskoi terapii u patsientov, perenesshikh ishemicheskii insul't. Rezolyutsiya Soveta ekspertov',
Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, vol. 120, no. 6, pp. 152-161.
https://doi.org/10.17116/jnevro2020120061152APA
Vozniuk, I. A., Shamalov, N. A., Ezhov, M. V., Tikhomirova, O. V.
, Gurevich, V. S., Kucherenko, S. S., Konovalov, G. A., Konstantinov, V. O., & Ershova, A. I. (2020).
Optimizatsiya gipolipidemicheskoi terapii u patsientov, perenesshikh ishemicheskii insul't. Rezolyutsiya Soveta ekspertov.
Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova,
120(6), 152-161.
https://doi.org/10.17116/jnevro2020120061152Vancouver
Author
Vozniuk, I. A. ; Shamalov, N. A. ; Ezhov, M. V. ; Tikhomirova, O. V.
; Gurevich, V. S. ; Kucherenko, S. S. ; Konovalov, G. A. ; Konstantinov, V. O. ; Ershova, A. I. /
Optimizatsiya gipolipidemicheskoi terapii u patsientov, perenesshikh ishemicheskii insul't. Rezolyutsiya Soveta ekspertov. In:
Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. 2020 ; Vol. 120, No. 6. pp. 152-161.
BibTeX
@article{86a76453fee74259aa32ccfaf050cb0f,
title = "Optimizatsiya gipolipidemicheskoi terapii u patsientov, perenesshikh ishemicheskii insul't. Rezolyutsiya Soveta ekspertov",
abstract = "Hyperlipidemia is the main risk factor for diseases caused by atherosclerosis including ischemic stroke. This publication provides practical recommendations and an algorithm for prescribing lipid-lowering therapy to post-ischemic stroke patients. The algorithm presents the steps for sequential administration of statins, ezetimibe, and PCSK9 inhibitors to achieve target levels of low-density lipoprotein cholesterol.",
keywords = "Anticholesteremic Agents, Brain Ischemia/drug therapy, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Proprotein Convertase 9, Stroke/drug therapy",
author = "Vozniuk, {I. A.} and Shamalov, {N. A.} and Ezhov, {M. V.} and Tikhomirova, {O. V.} and Gurevich, {V. S.} and Kucherenko, {S. S.} and Konovalov, {G. A.} and Konstantinov, {V. O.} and Ershova, {A. I.}",
note = "Funding Information: Совет Экспертов проводился при поддержке компании «Амджен». The Expert Council was supported by Amgen. Publisher Copyright: {\textcopyright} 2020, Media Sphera Publishing Group. All rights reserved.",
year = "2020",
doi = "10.17116/jnevro2020120061152",
language = "русский",
volume = "120",
pages = "152--161",
journal = "ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА",
issn = "1997-7298",
publisher = "Медицина",
number = "6",
}
RIS
TY - JOUR
T1 - Optimizatsiya gipolipidemicheskoi terapii u patsientov, perenesshikh ishemicheskii insul't. Rezolyutsiya Soveta ekspertov
AU - Vozniuk, I. A.
AU - Shamalov, N. A.
AU - Ezhov, M. V.
AU - Tikhomirova, O. V.
AU - Gurevich, V. S.
AU - Kucherenko, S. S.
AU - Konovalov, G. A.
AU - Konstantinov, V. O.
AU - Ershova, A. I.
N1 - Funding Information:
Совет Экспертов проводился при поддержке компании «Амджен». The Expert Council was supported by Amgen.
Publisher Copyright:
© 2020, Media Sphera Publishing Group. All rights reserved.
PY - 2020
Y1 - 2020
N2 - Hyperlipidemia is the main risk factor for diseases caused by atherosclerosis including ischemic stroke. This publication provides practical recommendations and an algorithm for prescribing lipid-lowering therapy to post-ischemic stroke patients. The algorithm presents the steps for sequential administration of statins, ezetimibe, and PCSK9 inhibitors to achieve target levels of low-density lipoprotein cholesterol.
AB - Hyperlipidemia is the main risk factor for diseases caused by atherosclerosis including ischemic stroke. This publication provides practical recommendations and an algorithm for prescribing lipid-lowering therapy to post-ischemic stroke patients. The algorithm presents the steps for sequential administration of statins, ezetimibe, and PCSK9 inhibitors to achieve target levels of low-density lipoprotein cholesterol.
KW - Anticholesteremic Agents
KW - Brain Ischemia/drug therapy
KW - Humans
KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW - Proprotein Convertase 9
KW - Stroke/drug therapy
UR - http://www.scopus.com/inward/record.url?scp=85088222272&partnerID=8YFLogxK
U2 - 10.17116/jnevro2020120061152
DO - 10.17116/jnevro2020120061152
M3 - Обзорная статья
C2 - 32678563
AN - SCOPUS:85088222272
VL - 120
SP - 152
EP - 161
JO - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА
JF - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА
SN - 1997-7298
IS - 6
ER -
